Catalyst calendar
Biotech catalysts in December 2026
5 catalysts are dated to December 2026, including 1 FDA decision. The first with a set day is the FDA decision on Relutrigine (Praxis Precision Medicines) on Dec 27. Events placed only in a quarter or half-year are on the 90-day calendar.
Firm dates · a specific day set by the company or regulator
Next 90 days
- Dec 27in 75 daysRelutrigine · FDA decision · SCN2A and SCN8A developmental and epileptic encephalopathy
Estimated timing · a month, quarter, half-year or year-end the company gave
Expected in December 2026
- December 2026CLN-978 · Results · Rheumatoid arthritis
- December 2026CLN-049 · Phase 1 results · Relapsed/refractory AML · MDS
- December 2026EP-104GI · Phase 2b topline results (RESOLVE) · Eosinophilic esophagitis
- December 2026KSI-101 · Phase 3 topline results (PEAK) · Macular Edema Secondary to Inflammation (MESI)